VHL and neoplasm: We describe the uptake of diagnostic and presymptomatic genetic testing in a series of 109 individuals for VHL disease, the results of the initial screening for VHL-related tumors in mutation-carriers, and the uptake and subsequent adherence to tumor surveillance over a five year period.